| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
5
5
2
4
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
C
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 7.42 | 7.42 |
| Stocks | 0.77 | 0.77 |
| Bonds | 0.0 | 0.0 |
| Other | 0.75 | 0.75 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 90.9 | 90.9 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.16 | 0.16 |
Updated 11.30.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 11.30.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| COSMOS Pharmaceutical Corporation | 3349 | --- | 2.11 |
| Shinsei Bank, Ltd. | 8303 | --- | 1.86 |
| Nihon Kohden Corporation | 6849 | --- | 1.61 |
| Filtrona PLC | FLRAF | 21.76 | 1.36 |
| Getinge AB | GETI B | --- | 1.18 |
| Primary Health Care Limited | PRY | --- | 1.14 |
| IRESS Limited | IRSMF | 3.89 | 1.11 |
| Euromoney Institutional Investor PLC | ERM | --- | 1.07 |
| Babcock International Group PLC | BAB | --- | 1.04 |
| Bic | BB | --- | 1.03 |
